Daniel Scott Lambert

Title: The Innovations of Daniel Scott Lambert

Introduction

Daniel Scott Lambert is an accomplished inventor based in Waterford, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and their applications. With a total of 2 patents to his name, Lambert continues to push the boundaries of scientific innovation.

Latest Patents

Lambert's latest patents include "Modified Cpn10 and PRR Signalling" and "Chaperonin 10 Variants." The first patent relates to isolated Cpn10 polypeptides that possess an increased affinity for a PRR ligand compared to the Ala Cpn10 polypeptide. This invention also encompasses modified chaperonin 10 polypeptides, nucleic acids encoding these polypeptides, and compositions that include them, along with their various uses. The second patent focuses on chaperonin 10 N-terminal variants, specifically those with enhanced immunomodulatory capacity and improved binding affinity for pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).

Career Highlights

Daniel Scott Lambert is associated with Cbio Limited, where he applies his expertise in biotechnology to advance research and development. His work has been instrumental in creating innovative solutions that address complex biological challenges.

Collaborations

Lambert has collaborated with notable colleagues, including Dean Jason Naylor and Richard James Brown. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Daniel Scott Lambert's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in his field. His work continues to inspire advancements in scientific research and innovation.